| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 6,446 | 3,173 | 2,162 | 6,602 | | Cost of Revenue | 4,879 | 2,929 | 2,699 | 6,885 | | | Gross Profit | 1,567 | 244 | (537) | (283) | | | Operating Expenses | | Research Development | 1,975 | 2,030 | 1,614 | 1,928 | | Selling General and Administrative | 2,115 | 2,120 | 1,935 | 2,787 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,523) | (3,906) | (4,086) | (4,998) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (96) | (27) | 257 | 10 | | Earnings Before Interest And Taxes | (2,544) | (3,933) | (3,829) | (4,988) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (2,544) | (3,933) | (3,829) | (4,988) | | Income Tax Expense | (458) | 31 | 18 | (31) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,086) | (3,964) | (3,847) | (4,957) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,086) | (3,964) | (3,847) | (4,957) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,086) | ($3,964) | ($3,847) | ($4,957) |
|
0.51% Nasdaq 
Income Statement
